Biodexa Pharmaceuticals Plc (BDRX) (CIK 0001643918) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001214659-25-014284
- Form
- CORRESP
- Filer
- Biodexa Pharmaceuticals Plc (BDRX) (CIK 0001643918)
- CIK
- 0001643918
- Ticker
- BDRX
- Filed
- 2025-09-29
- SIC industry
- 2834
- HQ
- Cardiff
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1643918/000121465925014284/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer